Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic foods, today announced that the Company will participate in the ICR Conference on Tuesday, January 13, 2026 in Orlando, Florida. Lifeway President and CEO Julie Smolyansky will discuss Lifeway’s explosive growth and role as the leading brand […]
EastGroup Properties, Inc. (NYSE: EGP) (the “Company” or “EastGroup”) announced today that it will hold its Fourth Quarter 2025 Earnings Conference Call and Webcast on Thursday, February 5, 2026, at 11:00 a.m. Eastern Time. On the call, senior management will discuss the Company’s fourth quarter results, current operations, and earnings outlook for 2026. EastGroup plans
Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference: — J.P. Morgan 2026 Healthcare Conference, San Francisco, CA. Brian Van Wagener, CFO, will present on Tuesday, January 13, 2026, at 1:30 p.m. Pacific Time. The above presentation will be webcast. Links to the live and archived webcast will be available on Veeva's
(NASDAQ:TVRD), HOUSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that management will deliver a company presentation during the 44th Annual J.P. Morgan Healthcare Conference, being held January 12th
-Updated logo and website better reflect patient-centric focus and accessibility as well as new inflection point for company- -ClinNEXUS management will be in attendance during “JPM Week” hosting investor meetings and sharing its new corporate presentation- LOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) — ClinNEXUS, (or the “Company”), a data-driven healthcare company that's redefining care
(NASDAQ:TMCI), PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its Lapiplasty(R) Lightning(TM) technology. Lightning technology expands
(NASDAQ:CIFR),(NASDAQ:CIFRW), NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a leader in the development of industrial-scale data centers, today announced its participation in several upcoming industry conferences. Cipher's CEO, Tyler Page, may be featured in various discussions highlighting the Company's recent developments and growth strategy. If
(NASDAQ:ICCC), PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced preliminary, unaudited sales results for the fourth quarter and full year of 2025. Since the first quarter of 2020, ImmuCell
(NASDAQ:ELDN), Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive preliminary results from first six patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study Tegoprubart continues to be used as key component of immunosuppression
(NASDAQ:TLRY),(TSX:TLRY), International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal Cannabis Rescheduling Expected to Unlock New Market Opportunity for Tilray Medical Expansion into the U.S. Strong Financial Position with $292 Million in Cash and Marketable Securities1 and ~$30 Million Net Cash NEW YORK and